REQUEST A DEMO
Total
USD $0.00
Search more companies

Ronald Pharmaceuticals Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Ronald Pharmaceuticals Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ronald Pharmaceuticals Private Limited is an unlisted company, incorporated on 26/04/1993. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24110GJ1993PTC019347 and registration number is 019347. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Block No 740/Aat Manjusar Tal Savli
Vadodara; Gujarat; Postal Code: 390007

Contact Details: Purchase the Ronald Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ronald Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Ronald Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 26, 1993
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
49.71%
Purchase this report to view the information.
25.01%
Company Performance
Financial values in the chart are available after Ronald Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
2.21%
Total operating revenue
2.29%
Operating profit (EBIT)
147.54%
EBITDA
100.78%
Net Profit (Loss) for the Period
137.71%
Total assets
16.16%
Total equity
56.59%
Operating Profit Margin (ROS)
3.3%
Net Profit Margin
2.38%
Return on Equity (ROE)
9.06%
Debt to Equity Ratio
3.8%
Quick Ratio
0.29%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?